[Effect of hemodilution and dehydration on regional cerebral circulation].
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D001921:Brain / Q000098:blood supply; D001925:Brain Damage, Chronic / Q000188:drug therapy; D001932:Brain Neoplasms / Q000188:drug therapy; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy; D006801:Humans; D007511:Ischemia; D010952:Plasma Substitutes / Q000494:pharmacology*; D011868:Radioisotopes; D013012:Sorbitol / Q000494:pharmacology / Q000627:therapeutic use; D014978:Xenon
D003911:Dextrans; D010952:Plasma Substitutes; D011868:Radioisotopes; D014978:Xenon; D013012:Sorbitol
Effekt von Hämodilution und Dehydratation auf die regionale Hirndurchblutung.